These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32130630)

  • 21. Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition.
    Ahmed RM; Highton-Williamson E; Caga J; Thornton N; Ramsey E; Zoing M; Kim WS; Halliday GM; Piguet O; Hodges JR; Farooqi IS; Kiernan MC
    J Alzheimers Dis; 2018; 61(2):773-783. PubMed ID: 29254092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis.
    Andrés-Benito P; Povedano M; Domínguez R; Marco C; Colomina MJ; López-Pérez Ó; Santana I; Baldeiras I; Martínez-Yelámos S; Zerr I; Llorens F; Fernández-Irigoyen J; Santamaría E; Ferrer I
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Verde F; Otto M; Silani V
    Front Neurosci; 2021; 15():679199. PubMed ID: 34234641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain Kynurenine Pathway Metabolite Levels May Reflect Extent of Neuroinflammation in ALS, FTD and Early Onset AD.
    Heylen A; Vermeiren Y; Kema IP; van Faassen M; van der Ley C; Van Dam D; De Deyn PP
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal imaging in
    Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
    Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
    Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
    J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia.
    Van Langenhove T; Piguet O; Burrell JR; Leyton C; Foxe D; Abela M; Bartley L; Kim WS; Jary E; Huang Y; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR
    J Alzheimers Dis; 2017; 58(1):163-170. PubMed ID: 28387671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia.
    Ahmed RM; Phan K; Highton-Williamson E; Strikwerda-Brown C; Caga J; Ramsey E; Zoing M; Devenney E; Kim WS; Hodges JR; Piguet O; Halliday GM; Kiernan MC
    Ann Clin Transl Neurol; 2019 Mar; 6(3):486-495. PubMed ID: 30911572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease.
    Wilke C; Gillardon F; Deuschle C; Dubois E; Hobert MA; Müller vom Hagen J; Krüger S; Biskup S; Blauwendraat C; Hruscha M; Kaeser SA; Heutink P; Maetzler W; Synofzik M
    Curr Alzheimer Res; 2016; 13(6):654-62. PubMed ID: 26971930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.
    Le Ber I; De Septenville A; Millecamps S; Camuzat A; Caroppo P; Couratier P; Blanc F; Lacomblez L; Sellal F; Fleury MC; Meininger V; Cazeneuve C; Clot F; Flabeau O; LeGuern E; Brice A;
    Neurobiol Aging; 2015 Nov; 36(11):3116.e5-3116.e8. PubMed ID: 26476236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease.
    Talbot K; Ansorge O
    Hum Mol Genet; 2006 Oct; 15 Spec No 2():R182-7. PubMed ID: 16987882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
    Jovičić A; Paul JW; Gitler AD
    J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the
    Dols-Icardo O; García-Redondo A; Rojas-García R; Borrego-Hernández D; Illán-Gala I; Muñoz-Blanco JL; Rábano A; Cervera-Carles L; Juárez-Rufián A; Spataro N; De Luna N; Galán L; Cortes-Vicente E; Fortea J; Blesa R; Grau-Rivera O; Lleó A; Esteban-Pérez J; Gelpi E; Clarimón J
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):162-168. PubMed ID: 28889094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
    Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
    EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models.
    Nolan M; Talbot K; Ansorge O
    Acta Neuropathol Commun; 2016 Sep; 4(1):99. PubMed ID: 27600654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
    Deng Z; Sheehan P; Chen S; Yue Z
    Mol Neurodegener; 2017 Dec; 12(1):90. PubMed ID: 29282133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emotion processing deficits distinguish pure amyotrophic lateral sclerosis from frontotemporal dementia.
    Savage SA; Lillo P; Kumfor F; Kiernan MC; Piguet O; Hodges JR
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):39-46. PubMed ID: 23889548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between TBK1 mutations and risk of amyotrophic lateral sclerosis/frontotemporal dementia spectrum: a meta-analysis.
    Cui R; Tuo M; Li P; Zhou C
    Neurol Sci; 2018 May; 39(5):811-820. PubMed ID: 29349657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A visual MRI atrophy rating scale for the amyotrophic lateral sclerosis-frontotemporal dementia continuum.
    Ambikairajah A; Devenney E; Flanagan E; Yew B; Mioshi E; Kiernan MC; Hodges JR; Hornberger M
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):226-34. PubMed ID: 24533506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.